Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George J Hutton

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Neurology|November 20, 2021
Clinical Reasoning: A 57-Year-Old Man With Stepwise Progressive Paraparesis, Sensory Loss, Urinary Retention, and ConstipationSamir Alkabie, Omar Tanweer, George J Hutton, et al.
Neurology|December 15, 2004
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosisRohit Bakshi, George J Hutton, James R Miller, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Prescribing of disease modifying agents in older adults with multiple sclerosisAshna Talwar, Jagadeswara R Earla, George J Hutton, et al.
Multiple Sclerosis and Related Disorders|July 7, 2020
Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical RecordsJagadeswara R Earla, George J Hutton, J Douglas Thornton, et al.
Biomedicines|April 2, 2020
Current Advances in Pediatric Onset Multiple SclerosisKristen S Fisher, Fernando X Cuascut, Victor M Rivera, et al.
Journal of Managed Care & Specialty Pharmacy|May 29, 2020
Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015Jagadeswara Rao Earla, J Douglas Thornton, George J Hutton, et al.
Multiple Sclerosis and Related Disorders|September 20, 2025
Comparative effectiveness and safety of glatopa and copaxone in patients with multiple sclerosisNing Lyu, Jieni Li, George J Hutton, et al.
Journal of Neuroimmunology|November 25, 2011
IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosisMeiyue Chen, Guangjie Chen, Shaohua Deng, et al.
Multiple Sclerosis and Related Disorders|March 12, 2021
The concurrence of multiple sclerosis and glioblastomaSamir Alkabie, Rhaisa Castrodad-Molina, Kent A Heck, et al.
Clinical Imaging|November 13, 2019
Histogram analysis of apparent diffusion coefficient and fluid-attenuated inversion recovery in discriminating between enhancing and nonenhancing lesions in multiple sclerosisKevin Yuqi Wang, Joshua Carlton, Danielle Guffey, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Neurology|November 20, 2021
Clinical Reasoning: A 57-Year-Old Man With Stepwise Progressive Paraparesis, Sensory Loss, Urinary Retention, and ConstipationSamir Alkabie, Omar Tanweer, George J Hutton, et al.
Neurology|December 15, 2004
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosisRohit Bakshi, George J Hutton, James R Miller, et al.
Multiple Sclerosis and Related Disorders|February 15, 2022
Prescribing of disease modifying agents in older adults with multiple sclerosisAshna Talwar, Jagadeswara R Earla, George J Hutton, et al.
Multiple Sclerosis and Related Disorders|July 7, 2020
Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical RecordsJagadeswara R Earla, George J Hutton, J Douglas Thornton, et al.
Biomedicines|April 2, 2020
Current Advances in Pediatric Onset Multiple SclerosisKristen S Fisher, Fernando X Cuascut, Victor M Rivera, et al.
Journal of Managed Care & Specialty Pharmacy|May 29, 2020
Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015Jagadeswara Rao Earla, J Douglas Thornton, George J Hutton, et al.
Multiple Sclerosis and Related Disorders|September 20, 2025
Comparative effectiveness and safety of glatopa and copaxone in patients with multiple sclerosisNing Lyu, Jieni Li, George J Hutton, et al.
Journal of Neuroimmunology|November 25, 2011
IFN-β induces the proliferation of CD4+CD25+Foxp3+ regulatory T cells through upregulation of GITRL on dendritic cells in the treatment of multiple sclerosisMeiyue Chen, Guangjie Chen, Shaohua Deng, et al.
Multiple Sclerosis and Related Disorders|March 12, 2021
The concurrence of multiple sclerosis and glioblastomaSamir Alkabie, Rhaisa Castrodad-Molina, Kent A Heck, et al.
Clinical Imaging|November 13, 2019
Histogram analysis of apparent diffusion coefficient and fluid-attenuated inversion recovery in discriminating between enhancing and nonenhancing lesions in multiple sclerosisKevin Yuqi Wang, Joshua Carlton, Danielle Guffey, et al.
Pageof 5